WEC
45
-5
DLTR
22
-10
MPC
36
-2
HON
52
4
STI
24
3
AMP
50
-8
PAYX
51
-3
EMR
47
-3
CSCO
37
-4
PRU
45
-6
HOG
35
-4
MAT
43
-4
CNX
50
-3
CINF
43
-2
MU
22
-6
NOC
56
2
URBN
24
-4
FITB
50
-5
CFG
38
-2
NTRS
32
-12
WEC
45
-5
DLTR
22
-10
MPC
36
-2
HON
52
4
STI
24
3
AMP
50
-8
PAYX
51
-3
EMR
47
-3
CSCO
37
-4
PRU
45
-6
HOG
35
-4
MAT
43
-4
CNX
50
-3
CINF
43
-2
MU
22
-6
NOC
56
2
URBN
24
-4
FITB
50
-5
CFG
38
-2
NTRS
32
-12
Financhill
Back

Celldex Therapeutics Quote, Financials, Valuation and Earnings

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Buy
58

CLDX
Celldex Therapeutics

Last Price:
43.77
Seasonality Move:
3.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Forget AI THIS is Way Bigger

If you've never heard of "QaaS" technology you need to click here now.

Celldex Therapeutics Price Quote

$43.77
+0.01 (+0.67%)
(Updated: September 7, 2024 at 6:26 AM ET)

Celldex Therapeutics Key Stats

Buy
58
Celldex Therapeutics (CLDX) is a Buy
Day range:
$42.78 - $44.13
52-week range:
$22.11 - $53.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
295.46
P/B ratio:
3.57%
Volume:
427.8K
Avg. volume:
735.3K
1-year change:
55.12%
Market cap:
$2.9B
Revenue:
$6.9M
EPS:
$-2.75

How Much Does Celldex Therapeutics Make?

Is Celldex Therapeutics Growing As A Company?

  • What Is Celldex Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 8.32%
  • What Is Celldex Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Celldex Therapeutics Stock Price Performance

What Is Celldex Therapeutics 52-Week High & Low?

Celldex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Celldex Therapeutics?

Is Celldex Therapeutics Cash Flow Positive?

  • What Is CLDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$121.5M
  • What Is Celldex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $657.5M
  • What Is Celldex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$521.4M

Celldex Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CLDX return on invested capital is -28.83%
  • What Is Celldex Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -27.22%
  • What Is CLDX Return On Equity?
    ROE is a measure of profitability and is -28.83%

Celldex Therapeutics Earnings Date & Stock Price

Celldex Therapeutics Competitors

Celldex Therapeutics Dividend Yield

Celldex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.99%
Revenue: 832.09% 192.41%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 67.00
Upside from Last Price: 53.11%

Major Shareholders

  • How many CLDX shares are owned by institutional investors?
    117M CLDX shares are owned by institutional investors
  • How many CLDX shares are owned by insiders?
    6.7M CLDX shares are owned by insiders